Viewing StudyNCT00513253



Ignite Creation Date: 2024-05-05 @ 6:36 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00513253
Status: WITHDRAWN
Last Update Posted: 2015-02-16
First Post: 2007-08-06

Brief Title: A Phase I Study to Test Alternate Oral Formulations vs the Current Tablet Formulation of Lapatinib
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Healthy Subjects
Keywords:
Name View
lapatinib View
Healthy Adult Volunteer View